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To determine the geographic distribution of the newly 
recognized human pathogen Rickettsia parkeri, we looked 
for	this	organism	in	ticks	from	Tennessee	and	Georgia,	USA.	
Using	PCR	and	sequence	analysis,	we	identified	R. parkeri 
in	2	Amblyomma americanum ticks. This rickettsiosis may 
be	underdiagnosed	in	the	eastern	United	States.
T
he most commonly reported rickettsial human patho-
gen  in  the  United  States  is  Rickettsia  rickettsii,  the 
causative agent of Rocky Mountain spotted fever (RMSF). 
First identified in 1937 (1), R. parkeri has been recognized 
as a human pathogen only since 2004, when it was isolated 
from an eschar on a serviceman from Virginia (2), although 
an Ohio patient suspected to have RMSF died of R. park-
eri rickettsiosis in 1990 (3). Little is known about the geo-
graphic distribution of R. parkeri in the United States or 
the epidemiology of the disease it causes. The primary vec-
tor of R. parkeri is thought to be the Gulf Coast tick (Am-
blyomma maculatum), and naturally infected Gulf Coast 
ticks have been reported in numerous southeastern states 
(4).  Experimentally,  A.  americanum  ticks  can  maintain 
and transmit R. parkeri (5); thus, this tick species, which 
is more abundant than A. maculatum and bites humans ag-
gressively (6), might contribute to R. parkeri transmission. 
To determine the geographic distribution of R. parkeri, we 
examined ticks collected in Tennessee and Georgia.
The Study
In  Georgia,  during  2005–2006,  residents  were  en-
couraged to submit ticks to the state’s Division of Public 
Health for identification and testing for various tick-borne 
pathogens. We studied only ticks that had been attached to 
persons. Ticks were individually homogenized with metal 
beads and resuspended in 225 μL of phosphate-buffered sa-
line. DNA was extracted from 100 μL of the homogenate 
by using a QIAamp DNA Micro Kit (QIAGEN Inc, Va-
lencia, CA, USA) according to the manufacturer’s instruc-
tions. We conducted a nested PCR targeting the 17-kDa 
gene (7) and used bidirectional sequencing at the Integrated 
Biotechnology Laboratories (University of Georgia, Ath-
ens, GA, USA) to confirm positive results.
In  Tennessee,  from  April  2007  through  September 
2008, the United States Department of Agriculture, Animal 
and Plant Health Inspection Service, Wildlife Services, and 
the Tennessee Department of Health collected A. america-
num and A. maculatum ticks from 31 counties by examin-
ing wild animals and dragging flannel sheets through veg-
etation. Ticks were stored in 100% ethanol and were sent to 
the Tennessee Department of Health Vector-Borne Diseas-
es Laboratory for identification of species and life stage and 
detection of pathogens by molecular testing. A PCR target-
ing the outer membrane protein A (rOmpA) gene of spotted 
fever group (SGF) rickettsiae was conducted as previously 
described, using primers Rr190.602n and Rr190.70p (8). 
To identify the rickettsiae species, we subjected positive 
samples  to  a  restriction  fragment  length  polymorphism 
(RFLP)  assay  by  digestion  of  the  amplicons  with  RsaI 
(Promega, Madison, WI, USA) and PstI (Fermentas, Glen 
Burnie, MD, USA) enzymes at 37°C for 2 h. Digested frag-
ments were subjected to electrophoresis on 10% polyacryl-
amide gels. To confirm species identification, we purified 
representative positive PCR products with Exosap-It (USB 
Corporation, Cleveland, OH, USA), sequenced at the Ten-
nessee Department of Health Laboratory Services (Nash-
ville, TN, USA) and entered into the National Center for 
Biotechnology Information BLAST database (www.blast.
ncbi.nlm.nih.gov/Blast.cgi). 
Of  ticks  collected  in  Georgia,  418  A.  americanum 
ticks (237 adults, 180 nymphs, and 1 unknown) and 19 A. 
maculatum ticks, were submitted for testing. Of these, 1 
A. americanum tick (Fayette County, May 2005) and 1 A. 
maculatum tick (Morgan County, July 2005) were positive 
for R. parkeri (100% identity with GenBank accession no. 
U17008).
Of 611 A. americanum and 2 A. maculatum ticks col-
lected in Tennessee, 446 A. americanum (164 adults and 
282 nymphs) and 2 A. maculatum adults were individually 
tested for Rickettsia spp. An additional 103 A. americanum 
larvae were divided in 10 pools of 4–19 ticks each accord-
ing to collection site. A single A. americanum adult male 
(0.2% of total) had a positive RFLP pattern that matched 
the previously described rOmpA gene pattern of R. parkeri 
(8). The sequence of this amplicon (532 bp, GenBank ac-
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a coyote in Knox County, Tennessee, in July 2007.
Conclusions
We  identified  R.  parkeri  in  ticks  in  Tennessee  and 
Georgia.  In  Tennessee,  our  identification  of  only  2  A. 
maculatum ticks (the primary vector of R. parkeri) sup-
ports previous reports that this tick species is uncommon in 
Tennessee (9). In Georgia, the 19 A. maculatum ticks iden-
tified were <5% of the total number of ticks collected in 
Georgia. In contrast to these low numbers, A. americanum 
ticks are ubiquitous in high densities throughout the other 
southeastern states and readily feed on humans (8). Re-
cently, the range of A. americanum ticks has expanded in 
the United States and now extends from west-central Texas 
to the Atlantic Coast, encompassing the entire Southeast 
and parts of the lower Midwest and coastal New England 
(10). The distribution of A. americanum ticks completely 
overlaps the suspected distribution of A. maculatum ticks 
(Figure). The positive A. americanum tick from Tennessee 
was collected from a free-ranging coyote, and the detected 
R. parkeri may have been present in the blood meal taken 
by the tick. However, A. americanum ticks can maintain 
and transmit R. parkeri infection both transovarially and 
transtadially (6). R. parkeri has previously been identified 
in A. maculatum ticks from Georgia (4), but the identifica-
tion of R. parkeri in A. americanum ticks renews concerns 
that this tick species may be involved in the natural history 
of another zoonotic pathogen. Additional study is needed to 
determine the extent of the role of A. americanum ticks as 
a natural vector for R. parkeri.
This study raises concerns about the serologic diagno-
sis of RMSF. R. parkeri may be the etiologic agent of some 
rickettsiosis cases in Tennessee and Georgia that have been 
misdiagnosed  as  RMSF.  Because  reliable  clinical  tests 
specific for different SFG rickettsiae are not readily avail-
able, several different rickettsioses may be serologically 
cross-reactive, leading to misdiagnosis of RMSF (11–14). 
Reliable diagnosis requires PCR or culture of biopsy speci-
mens from eschars, when present (15). Additional studies 
characterizing SFG rickettsioses, including development of 
rickettsial species–specific clinical tests, will assist in at-
tributing rickettsiosis to R. rickettsii, R. parkeri, or other 
SFG rickettsial infections.
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